Advertisement

An Empirical Quantitative Model Describing Simultaneously Temperature and Concentration Effects on Protein Solution Viscosity

Published:December 07, 2019DOI:https://doi.org/10.1016/j.xphs.2019.12.001

      Abstract

      The viscosity of high-concentration protein solutions can lead to a range of challenges in drug product manufacturing and administration. Accurately modeling the viscosity of biologics solutions in response to changes in the formulation and surrounding environment is of significant interest and remains a challenge. Here, we show a practical method of modeling the viscosity of a therapeutic solution in response to changes in temperature and protein concentration. Our viscosity model consists of a Ross-Minton model of concentration dependence and a modified Arrhenius temperature dependence. We measured the viscosity as a function of concentration and temperature of 4 therapeutic antibodies in a range of potential clinical formulations. With these data, our model shows surprising generality, proving effective with different types of antibodies, formulations, and a range of more than 2 orders of magnitude in viscosity. Our approach is built on existing theory but provides a practical approach to modeling the viscosity of formulated drug product over the range of process-relevant concentrations and temperatures to better mitigate challenges in the drug manufacturing process.

      Keywords

      To read this article in full you will need to make a payment
      APhA Member Login
      APhA Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shire S.J.
        • Shahrokh Z.
        • Liu J.
        Challenges in the development of high protein concentration formulations.
        J Pharm Sci. 2004; 93: 1390-1402
        • Shire S.J.
        Formulation and manufacturability of biologics.
        Curr Opin Biotechnol. 2009; 20: 708-714
        • Garidel P.
        • Kuhn A.B.
        • Schäfer L.V.
        • et al.
        High-concentration protein formulations: how high is high?.
        Eur J Pharm Biopharm. 2017; 119: 353-360
        • Yadav S.
        • Shire S.J.
        • Kalonia D.S.
        Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
        J Pharm Sci. 2010; 99: 4812-4829
        • Jezek J.
        • Rides M.
        • Derham B.
        • et al.
        Viscosity of concentrated therapeutic protein compositions.
        Adv Drug Deliv Rev. 2011; 63: 1107-1117
        • Yadav S.
        • Laue T.M.
        • Kalonia D.S.
        • et al.
        The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions.
        Mol Pharm. 2012; 9: 791-802
        • Galush W.J.
        • Le L.N.
        • Moore J.M.R.
        Viscosity behavior of high-concentration protein mixtures.
        J Pharm Sci. 2012; 101: 1012-1020
        • Burckbuchler V.
        • Mekhloufi G.
        • Giteau A.P.
        • et al.
        Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions.
        Eur J Pharm Biopharm. 2010; 76: 351-356
        • Chari R.
        • Jerath K.
        • Kalonia D.S.
        Long- and short-range electrostatic interactions affect the rheology of highly concentrated antibody solutions.
        J Pharm Res. 2009; 26: 2607-2618
        • Lilyestrom W.G.
        • Yadav S.
        • Shire S.J.
        Monoclonal antibody self-association, cluster formation, and rheology at high concentrations.
        J Phys Chem B. 2013; 117: 6373-6384
        • Hanslip S.
        • Desai K.G.
        • Palmer M.
        • et al.
        Syringe filling of high-concentration monoclonal antibody formulation: slow suck back pump speed prevented filling needle clogging.
        J Pharm Sci. 2017; 106: 3651-3653
        • Shieu W.
        • Torhan S.A.
        • Chan E.
        • et al.
        Filling of high-concentration monoclonal antibody formulations into pre-filled syringes: filling parameter investigation and optimization.
        PDA J Pharm Sci Technol. 2014; 68: 153-163
        • Schmit J.D.
        • He F.
        • Mishra S.
        • et al.
        J. Entanglement model of antibody viscosity.
        J Phys Chem B. 2014; 118: 5044-5049
        • Pusey P.N.
        • van Megen W.
        Phase behavior of concentrated suspensions of nearly hard colloidal spheres.
        Nature. 1986; 320: 340-342
        • Pusey P.N.
        Colloidal glasses.
        J Phys Condens Matter. 2008; 20: 494202-494207
        • Pusey P.N.
        Chapter 10, colloidal suspensions.
        in: Hansen J.P. Levesque D. Zinn-Justin J. Liquids, Freezing and Glass Transition. Elsevier Science & Technology, Amsterdam1991: 763-942
        • Batchelor G.K.
        The effect of Brownian motion on the bulk stress in a suspension of spherical particles.
        J Fluid Mech. 1977; 83: 97-117
        • Zarraga I.E.
        • Taing R.
        • Zarzar J.
        • et al.
        High shear rheology and anisotropy in concentrated solutions of monoclonal antibodies.
        J Pharm Sci. 2013; 102: 2538-2549
        • Brandt J.P.
        • Patapoff T.W.
        • Aragon S.R.
        Construction, MD simulation, and hydrodynamic validation of an all-atom model of a monoclonal IgG antibody.
        Biophys J. 2010; 99: 905-913
        • Russel W.B.
        • Wagner N.J.
        • Mewis J.
        Divergence in the low shear viscosity for Brownian hard-sphere dispersions: at random close packing or the glass transition?.
        J Rheol. 2013; 57: 1555-1567
        • Russel W.B.
        • Saville D.A.
        • Schowalter W.R.
        Colloidal Dispersions.
        Cambridge University Press, New York, NY1989: 406-505
        • Krieger M.
        • Dougherty T.J.
        A mechanism for non-Newtonian flow in suspensions of rigid spheres.
        Trans Soc Rheol. 1959; 3: 137-152
        • Mooney M.
        The viscosity of a concentrated suspension of spherical particles.
        J Colloid Sci. 1951; 6: 162-170
        • Ross P.D.
        • Minton A.P.
        Hard quasispherical model for the viscosity of hemoglobin solutions.
        Biochem Biophys Res Commun. 1977; 76: 971-976
        • Minton A.P.
        Hard quasispherical particle models for the viscosity of solutions of protein mixtures.
        J Phys Chem B. 2012; 116: 9310-9315
        • Monkos K.
        Concentration and temperature dependence of viscosity in lysozyme aqueous solutions.
        Biochim Biophys Acta. 1997; 1339: 304-310
        • Monkos K.
        Concentration and temperature dependence of viscosity in lysozyme aqueous solutions.
        Biophys Chem. 2000; 85: 7-16
        • Monkos K.
        A comparison of the activation energy of viscous flow for hen egg-white lysozyme obtained on the basis of different models of viscosity for glass forming liquids.
        Curr Top Biophys. 2011; 34: 1-9